Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Biocontrol Sci ; 25(2): 45-53, 2020.
Article in English | MEDLINE | ID: mdl-32507790

ABSTRACT

Povidone-iodine (PVP-I) is used for infection control and preoperative sterilization of the oral and pharyngeal regions. Marketed preparations containing cetylpyridinium chloride (CPC) are used to inhibit growth of oral bacteria. We conducted an in vitro study of the sterilizing effects of these microbicides on 10 oral bacterial strains and fungi related to pneumonia and periodontal disease, after dilution with phosphate-buffered saline (PBS), saliva, and components in saliva. The CPC solution was evaluated at 50 mg/100 mL, which is the concentration used in products. CPC sterilized all strains within 1 minute. Prolongation of the sterilization time associated with dilution was more gradual in comparison to PVP-I solution. CPC sterilized 7 of 10 microbial strains within 3 minutes at 3 mg/100 mL. At 500 mg/100 mL, which is near the upper limit of the concentration that is actually used, PVP-I solution sterilized 7 microbial strains within 3 minutes. However, PVP-I had no sterilization effect when diluted to 100 mg/100 mL or lower. With addition of saliva, PVP-I sterilized 2 microbial strains within 3 minutes at 500 mg/100 mL, whereas CPC solution sterilized 9 microbial strains within 1 minute at 50 mg/100 mL. Our results show that in use influenced by dilution with saliva, CPC is likely to maintain a strong sterilization effect, whereas PVP-I may have a reduced effect.


Subject(s)
Anti-Infective Agents, Local/pharmacology , Cetylpyridinium/pharmacology , Povidone-Iodine/pharmacology , Sterilization/methods , Candida albicans/drug effects , Candida albicans/growth & development , Clostridiales/drug effects , Clostridiales/growth & development , Fusobacterium nucleatum/drug effects , Fusobacterium nucleatum/growth & development , Humans , Microbial Sensitivity Tests , Porphyromonas gingivalis/drug effects , Porphyromonas gingivalis/growth & development , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Saliva/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Streptococcus constellatus/drug effects , Streptococcus constellatus/growth & development , Streptococcus intermedius/drug effects , Streptococcus intermedius/growth & development , Streptococcus mutans/drug effects , Streptococcus mutans/growth & development , Streptococcus pneumoniae/drug effects , Streptococcus pneumoniae/growth & development
2.
J Mol Biol ; 430(21): 4344-4358, 2018 10 19.
Article in English | MEDLINE | ID: mdl-30194969

ABSTRACT

Gram-positive bacteria deploy the type VII secretion system (T7SS) to facilitate interactions between eukaryotic and prokaryotic cells. In recent work, we identified the TelC protein from Streptococcus intermedius as a T7SS-exported lipid II phosphatase that mediates interbacterial competition. TelC exerts toxicity in the inner wall zone of Gram-positive bacteria; however, intercellular intoxication of sister cells does not occur because they express the TipC immunity protein. In the present study, we sought to characterize the molecular basis of self-protection by TipC. Using sub-cellular localization and protease protection assays, we show that TipC is a membrane protein with an N-terminal transmembrane segment and a C-terminal TelC-inhibitory domain that protrudes into the inner wall zone. The 1.9-Å X-ray crystal structure of a non-protective TipC paralogue reveals that the soluble domain of TipC proteins adopts a crescent-shaped fold that is composed of three α-helices and a seven-stranded ß-sheet. Subsequent homology-guided mutagenesis demonstrates that a concave surface formed by the predicted ß-sheet of TipC is required for both its interaction with TelC and its TelC-inhibitory activity. S. intermedius cells lacking the tipC gene are susceptible to growth inhibition by TelC delivered between cells; however, we find that the growth of this strain is unaffected by endogenous or overexpressed TelC, although the toxin accumulates in culture supernatants. Together, these data indicate that the TelC-inhibitory activity of TipC is only required for intercellularly transferred TelC and that the T7SS apparatus transports TelC across the cell envelope in a single step, bypassing the cellular compartment in which it exerts toxicity en route.


Subject(s)
Bacterial Toxins/metabolism , Streptococcus intermedius/growth & development , Type VII Secretion Systems/chemistry , Type VII Secretion Systems/metabolism , Cell Membrane/metabolism , Crystallography, X-Ray , Mutation , Protein Binding , Protein Conformation, alpha-Helical , Protein Conformation, beta-Strand , Streptococcus gallolyticus/genetics , Streptococcus gallolyticus/growth & development , Streptococcus gallolyticus/immunology , Streptococcus intermedius/genetics , Streptococcus intermedius/immunology , Type VII Secretion Systems/genetics
3.
Elife ; 62017 07 11.
Article in English | MEDLINE | ID: mdl-28696203

ABSTRACT

The Firmicutes are a phylum of bacteria that dominate numerous polymicrobial habitats of importance to human health and industry. Although these communities are often densely colonized, a broadly distributed contact-dependent mechanism of interbacterial antagonism utilized by Firmicutes has not been elucidated. Here we show that proteins belonging to the LXG polymorphic toxin family present in Streptococcus intermedius mediate cell contact- and Esx secretion pathway-dependent growth inhibition of diverse Firmicute species. The structure of one such toxin revealed a previously unobserved protein fold that we demonstrate directs the degradation of a uniquely bacterial molecule required for cell wall biosynthesis, lipid II. Consistent with our functional data linking LXG toxins to interbacterial interactions in S. intermedius, we show that LXG genes are prevalent in the human gut microbiome, a polymicrobial community dominated by Firmicutes. We speculate that interbacterial antagonism mediated by LXG toxins plays a critical role in shaping Firmicute-rich bacterial communities.


Subject(s)
Antibiosis , Bacterial Adhesion , Bacterial Toxins/metabolism , Streptococcus intermedius/physiology , Bacterial Toxins/chemistry , Crystallography, X-Ray , Humans , Microbial Viability/drug effects , Models, Molecular , Protein Conformation , Streptococcus intermedius/growth & development , Streptococcus intermedius/metabolism
4.
Caries Res ; 49(2): 165-76, 2015.
Article in English | MEDLINE | ID: mdl-25634570

ABSTRACT

A selected group of oral bacteria commonly associated with dental health is capable of producing alkali via the arginine deiminase system (ADS), which has a profound impact on the pH of human oral biofilms. An increased risk for dental caries has been associated with reduced ADS activity of the bacteria in oral biofilms. Arginolytic bacterial strains from dental plaque samples of caries-free and caries-active adults were isolated and characterized to investigate the basis for differences in plaque ADS activity between individuals. Fifty-six ADS-positive bacterial strains were identified by 16S rRNA gene sequencing, and their ADS activity levels were compared under standard growth conditions. The spectrum of bacterial ADS activity ranged from 45.2 to 688.0 units (mg protein)(-1). Although Streptococcus sanguinis was the most prevalent species, other Streptococcus sp. were also represented. Biochemical assays carried out using 27 ADS-positive strains under conditions known to induce or repress ADS gene expression showed substantial variation in arginolytic activity in response to pH, oxygen and the availability of carbohydrate or arginine. This study reveals that the basis for the wide spectrum of arginolytic expression observed among clinical strains is, at least in part, attributable to differences in the regulation of the ADS within and between species. The results provide insights into the microbiological basis for intersubject differences in ADS activity in oral biofilms and enhance our understanding of dental caries as an ecologically driven disease in which arginine metabolism moderates plaque pH and promotes dental health.


Subject(s)
Biofilms , Dental Plaque/microbiology , Homeostasis/physiology , Hydrolases/metabolism , Streptococcus/classification , Adult , Arginine/metabolism , Bacteriological Techniques , Carbohydrate Metabolism , DMF Index , Dental Caries/microbiology , Gene Expression Regulation, Enzymologic/genetics , Humans , Hydrogen-Ion Concentration , Hydrolases/genetics , Oxygen/metabolism , RNA, Ribosomal, 16S/genetics , Streptococcus/enzymology , Streptococcus/growth & development , Streptococcus gordonii/enzymology , Streptococcus gordonii/growth & development , Streptococcus intermedius/enzymology , Streptococcus intermedius/growth & development , Streptococcus sanguis/enzymology , Streptococcus sanguis/growth & development
5.
J Appl Microbiol ; 115(1): 260-70, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23551549

ABSTRACT

AIMS: The aim of this study was to clarify the effects of homologous and heterologous extracellular DNAs (eDNAs) and histone-like DNA-binding protein (HLP) on Streptococcus intermedius biofilm development and rigidity. METHODS AND RESULTS: Formed biofilm mass was measured with 0·1% crystal violet staining method and observed with a scanning electron microscope. The localizations of eDNA and extracellular HLP (eHLP) in formed biofilm were detected by staining with 7-hydoxyl-9H-(1,3-dichloro-9,9-dimethylacridin-2-one) and anti-HLP antibody without fixation, respectively. DNase I treatment (200 U ml(-1)) markedly decreased biofilm formation and cell density in biofilms. Colocalization of eHLP and eDNA in biofilm was confirmed. The addition of eDNA (up to 1 µg ml(-1)) purified from Strep. intermedius, other Gram-positive bacteria, Gram-negative bacteria, or human KB cells into the Strep. intermedius culture increased the biofilm mass of all tested strains of Strep. intermedius, wild-type, HLP-downregulated strain and control strains. In contrast, the addition of eDNA (>1 µg ml(-1)) decreased the biofilm mass of all Strep. intermedius strains. CONCLUSIONS: These findings demonstrated that eDNA and eHLP play crucial roles in biofilm development and its rigidity. SIGNIFICANCE AND IMPACT OF THE STUDY: eDNA- and HLP-targeting strategies may be applicable to novel treatments for bacterial biofilm-related infectious diseases.


Subject(s)
Biofilms/growth & development , DNA-Binding Proteins/metabolism , DNA/pharmacology , Streptococcus intermedius/physiology , Biofilms/drug effects , Cell Line, Tumor , DNA/analysis , DNA-Binding Proteins/analysis , Deoxyribonuclease I , Humans , Streptococcus intermedius/drug effects , Streptococcus intermedius/growth & development
6.
Mol Microbiol ; 68(5): 1268-82, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18410499

ABSTRACT

Streptococcus intermedius histone-like DNA-binding protein (Si-HLP) is a homodimeric protein and, conserved with Escherichia coli HU, a well-documented nucleoid-associated protein (NAP). In E. coli, HU plays important roles as both structural and regulatory factors, but it is not essential for E. coli viability. Streptococcal HLP has been found to bind host cells and induce cytokine production, but its physiological role remains poorly defined. In the present study, using gene insertion knockout and tetracycline-regulated antisense RNA expression techniques, we determined whether Si-HLP is essential for bacterial viability and normal growth in S. intermedius. The Si-HLP-downregulated S. intermedius strain showed alterations in its morphology and surface properties. Downregulation of Si-HLP led to an expanded nucleoid to fill the intracellular space. Transcription levels of several genes, including virulence-associated factors, were found to be activated or repressed in the antisense Si-hlp RNA-expressing strain by real-time PCR and reverse-transcription PCR. Collectively, these data suggest that Si-HLP serves as an essential NAP governing the nucleoid architecture and controlling the gene transcription profile in S. intermedius.


Subject(s)
Bacterial Proteins/metabolism , DNA-Binding Proteins/metabolism , Microbial Viability , Streptococcus intermedius/growth & development , Streptococcus intermedius/physiology , Transcription, Genetic , Bacterial Proteins/genetics , Bacterial Proteins/isolation & purification , DNA-Binding Proteins/genetics , DNA-Binding Proteins/isolation & purification , Escherichia coli Proteins/metabolism , Gene Expression Regulation, Bacterial , Histones , Streptococcus intermedius/genetics
7.
J Dent ; 34(6): 363-71, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16239058

ABSTRACT

OBJECTIVES: To measure antibacterial action of photoactivated disinfection (PAD) on endodontic bacteria in planktonic suspension and root canals. METHODS: Four bacteria, Fusobacterium nucleatum,Peptostreptococcus micros, Prevotella intermedia and Streptococcus intermedius, were tested in suspension. After mixing equal volumes of Tolonium chloride and bacterial suspension for 60s, each 200 microL of concentration (>10(6)cfu mL(-1)) was irradiated with light at 633+/-2 nm. Each energy dose/Tolonium chloride concentration combination was tested eight times, with controls. Prepared root canals in Training Blocs and extracted human teeth were inoculated with S. intermedius followed by 10 mg L(-1) Tolonium chloride or saline. Bacteria in canals were sampled before and after light irradiation. Student t-test assessed significance of changes in viable bacteria produced by treatment of either light or Tolonium chloride alone and light/Tolonium chloride combinations. RESULTS: In suspension, reductions in bacteria were highly significant (P<0.01) for light/Tolonium chloride combinations compared to light or Tolonium chloride alone. Maximum mean log reductions of 1.14 (P. intermedia), 2.48 (P. micros), 2.81 (F. nucleatum) and 6.73 (S. intermedius) were at 4.8 J/20 mg L(-1). Antibacterial action was increased by energy dose increase (not always significantly), but not by Tolonium chloride concentration. In control canals mean log reductions of 0.42 (Blocs) and 0.38 (teeth) from initial levels were not significant. PAD mean log reductions of 2.40 (Blocs) and 2.01 (teeth) were highly significant. Changes for PAD/energy dose combinations were not significant. CONCLUSION: PAD killed endodontic bacteria at statistically significant levels compared to controls. Kills varied with bacterial species.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Dental Pulp Cavity/microbiology , Disinfection/methods , Photochemotherapy/methods , Photosensitizing Agents/therapeutic use , Colony Count, Microbial , Fusobacterium nucleatum/drug effects , Fusobacterium nucleatum/growth & development , Humans , Laser Therapy , Peptostreptococcus/drug effects , Peptostreptococcus/growth & development , Prevotella intermedia/drug effects , Prevotella intermedia/growth & development , Streptococcus intermedius/drug effects , Streptococcus intermedius/growth & development , Tolonium Chloride/therapeutic use
8.
FEMS Microbiol Lett ; 243(2): 379-84, 2005 Feb 15.
Article in English | MEDLINE | ID: mdl-15686838

ABSTRACT

Intermedilysin is a cytolytic toxin produced by Streptococcus intermedius, a pathogen of humans. In vitro studies showed that exposure of S. intermedius to sub-minimum inhibitory concentration (MIC) levels (1/2 MIC) of protein-inhibiting antibiotics and nucleic acid-inhibiting antibiotics decreased intermedilysin release by S. intermedius. The most potent antibiotic was clindamycin. On the other hand, exposure to cell wall-inhibiting antibiotics generally showed insignificant changes in intermedilysin release at sub-MIC concentrations. Investigations into possible mechanisms underlying this sub-MIC effect with clindamycin showed that there was selective decrease in biosynthesis and release of toxin after exposure to 1/2 MIC condition. However, no significant differences in the mRNA levels of the intermedilysin gene were observed.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Streptococcus intermedius/drug effects , Bacterial Proteins/genetics , Bacterial Toxins/genetics , Bacterial Toxins/metabolism , Bacteriocins , Clindamycin/pharmacology , Humans , Microbial Sensitivity Tests , RNA, Messenger/genetics , RNA, Messenger/metabolism , Streptococcus intermedius/growth & development , Streptococcus intermedius/metabolism
9.
Caries Res ; 37(6): 395-403, 2003.
Article in English | MEDLINE | ID: mdl-14571116

ABSTRACT

The intent of this study was to compare the inherent acid tolerance of bacteria in samples of dental plaque from tooth sites in subjects with and without initial caries. Plaque was collected from approximal surfaces showing early enamel caries and from healthy tooth surfaces in the same subjects, as well as from enamel surfaces of caries-free individuals. In addition to plating on blood agar, the plaque samples were plated directly on non-selective solid agar medium buffered to pH 7.0, 6.0, 5.5, 5.0, 4.5 and 4.0 to avoid any loss of adaptation to acid during primary isolation of plaque bacteria. The results showed that approximately 50% of the total cultivable plaque microbiota from caries, as well as healthy tooth sites, was able to grow at pH 5.5 and 1% at pH 5.0, pH values regarded as critical for the demineralization of tooth enamel. At pH 5.0, members of the genus Streptococcus were the dominant group, but mutans streptococci accounted for less than half of the streptococcal viable count. The other acid-tolerant streptococcal isolates included Streptococcus anginosus, Streptococcus constellatus, Streptococcus gordinii, Streptococcus intermedius, Streptococcus mitis, Streptococcus oralis, Streptococcus salivarius and SStreptococcus sanguis. Analysis of the results indicated that the mutans streptococci in dental plaque were highly variable with respect to acid tolerance, and that both caries and healthy sites harboured significant numbers of mutans streptococci that were not acid-tolerant.


Subject(s)
Actinomyces/growth & development , Dental Caries/microbiology , Dental Enamel/microbiology , Dental Plaque/microbiology , Lactobacillus/growth & development , Streptococcus/growth & development , Acids , Actinomyces/classification , Adaptation, Physiological/physiology , Adolescent , Child , Colony Count, Microbial , Culture Media , Humans , Hydrogen-Ion Concentration , Lactobacillus/classification , Lacticaseibacillus casei/growth & development , Streptococcus/classification , Streptococcus anginosus/growth & development , Streptococcus constellatus/growth & development , Streptococcus intermedius/growth & development , Streptococcus mitis/growth & development , Streptococcus mutans/growth & development , Streptococcus oralis/growth & development , Streptococcus sanguis/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...